Sign for Notice Everyday    注册| 登陆| 友情链接| English|

Our Sponsors


    MEDICAL DEVICES 2011 - How to reduce EO residuals in medical devices - Medical Devices webinar By ComplianceOnline

    View: 581

    Website http://complianceonline.com/ecommerce/control/trainingFocus/~product_id=701798?channel=ourglocal | Want to Edit it Edit Freely

    Category Medical Devices,conference,event,Webinar

    Deadline: January 26, 2011 | Date: January 26, 2011

    Venue/Country: Palo Alto, U.S.A

    Updated: 2010-12-03 18:14:22 (GMT+9)

    Call For Papers - CFP

    Why Should You Attend:

    The revision to ISO 10993-7:2008 Biological Evaluation of Medical Devices?Part 7: Ethylene Oxide Sterilization Residuals, significantly reduced the amount of residual EO or its by-products allowed to be left on Medical devices. The transition period defined to reach compliance with the new EO residual limits ends on October 2011. The new EO residual limits impose a tremendous challenge as it’s requires a significant investment of time, effort and capital in middle of a tough economic climate.

    This webinar will offer ways to re-evaluate, re-design, or re-engineer your products, test methods and/or sterilization process to find opportunities for the simplest, fastest and most economical solutions to the problem. Additionally this webinar will offer ideas to transform a challenge into a potential opportunity for cost reduction. We will also discuss the practical approach to fulfill the regulation requirements.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.